Oestrogel Side Effects: Complete Safety Guide

When Do Oestrogel Side Effects Start & Common Side Effects

Most side effects occur within the first few months of starting Oestrogel, as your body adapts to oestrogen replacement. According to the Summary of Product Characteristics (SmPC), the following common side effects (affecting up to 1 in 10 people) have been reported:

• Breast pain and tenderness – often starts in the first weeks and usually subsides after 3–6 months.
• Headache – can occur within days of starting and typically resolves as treatment continues.
• Nausea and abdominal pain – usually transient and may be minimised by applying the gel after meals.
• Irregular bleeding or spotting – common in the first 3–6 months, especially if you still have a uterus. This often settles with time.
• Weight changes, vaginal discharge, painful periods – can occur early in treatment and usually stabilise.

These side effects are generally mild and temporary. If they persist or become severe, consult your doctor – a dose adjustment or change in regimen may help.

How Long Do Oestrogel Side Effects Last: Timeline

The duration of side effects varies by individual, but a typical timeline is as follows:

• First 1–3 months: Breast tenderness, nausea, headache, and irregular bleeding are most common. These usually peak within the first few weeks and gradually improve.
• 3–6 months: For many women, most initial side effects resolve completely as the body reaches hormonal balance. If bleeding persists beyond 6 months, your doctor should investigate.
• Long‑term risks: Serious side effects such as breast cancer, blood clots, and stroke do not appear immediately but increase with prolonged use (especially beyond 5 years). These risks are dose‑ and duration‑dependent.

If side effects are intolerable or do not improve after 3 months, your doctor may consider switching to a different HRT formulation (patch, tablet, or different progestogen combination).

Serious Side Effects & When to Seek Medical Help

HRT, including Oestrogel, is associated with an increased risk of certain serious conditions. These are rare but require awareness:

• Breast cancer: The risk increases with duration of use. For combined oestrogen‑progestogen HRT, there may be 4–8 extra cases per 1000 users over 5 years compared to non‑users. Regular breast screening is essential.
• Endometrial cancer (in women with uterus): Oestrogen‑only HRT increases the risk unless a progestogen is added. Taking a progestogen for at least 12 days per cycle protects the endometrium.
• Venous thromboembolism (blood clots): The risk is about 1.3–3 times higher in HRT users, especially during the first year. Factors like obesity, surgery, and family history increase risk.
• Stroke and heart disease: Slight increase in risk, particularly in women over 60 and those with existing cardiovascular risk factors.
• Gallbladder disease: HRT may increase the risk of gallstones.
• Ovarian cancer: A small increase in risk has been observed with long‑term use.

When to seek immediate medical help: If you develop any of the following, stop Oestrogel and contact a doctor or go to A&E:

• Sudden chest pain, breathlessness, or coughing up blood – possible pulmonary embolism.
• Painful swelling, redness, or warmth in one leg – possible deep vein thrombosis.
• Severe headache, confusion, or sudden vision changes – possible stroke.
• Yellowing of skin or eyes – liver problem.
• Swelling of face, tongue, or throat – allergic reaction.

Contraindications: Who Should NOT Use Oestrogel

Oestrogel is not suitable for everyone. Do not use this medicine if any of the following apply:

• Allergy (hypersensitivity) to estradiol or any other ingredient (carbomer, trolamine, ethanol).
• Current or past breast cancer, or suspected breast cancer.
• Oestrogen‑sensitive cancer (e.g., endometrial cancer).
• Unexplained vaginal bleeding.
• Untreated endometrial hyperplasia.
• Current or past venous thromboembolism (deep vein thrombosis, pulmonary embolism).
• Known thrombophilic disorder (e.g., protein C, protein S deficiency).
• Recent arterial thromboembolic disease (heart attack, stroke, angina).
• Liver disease with abnormal liver function tests.
• Porphyria.
• Pregnancy or breastfeeding.

If any of these conditions develop while using Oestrogel, stop immediately and consult your doctor. Your doctor will perform a thorough medical history and examination before prescribing HRT.

Food & Drug Interactions

Food interactions: There are no specific food restrictions with Oestrogel. However, alcohol may exacerbate side effects such as nausea, breast tenderness, or flushing in some women. It is advisable to limit alcohol consumption, especially when starting treatment.

Drug interactions: Certain medicines can reduce the effectiveness of Oestrogel, leading to irregular bleeding or loss of symptom control. These include:

• Enzyme inducers: Phenobarbital, phenytoin, carbamazepine (epilepsy); rifampicin, rifabutin (tuberculosis); nevirapine, efavirenz, ritonavir, nelfinavir (HIV); and St. John’s Wort (herbal remedy).
• Lamotrigine: Oestrogen can reduce lamotrigine levels, potentially increasing seizure frequency.
• Other topical products: Applying skin cleansers, detergents, or other skin medications (e.g., acne treatments, wart removers) to the same area before the gel dries may affect absorption.

Always inform your doctor and pharmacist about all medicines you take, including over‑the‑counter products and herbal supplements. If you need a blood test, tell the laboratory you use Oestrogel as it may affect some results (e.g., thyroid function tests).

Oestrogel Side Effects FAQs

Need Expert Advice on Oestrogel Side Effects?

If you are experiencing side effects or have concerns about HRT safety, our UK‑registered doctors can review your symptoms and adjust your treatment plan.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | Ongoing clinical support